Log in to save to my catalogue

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreas...

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreas...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6595219

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity

About this item

Full title

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2013-09, Vol.4 (1), p.2384-2384, Article 2384

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The antioxidant tempol reduces obesity in mice. Here we show that tempol alters the gut microbiome by preferentially reducing the genus
Lactobacillus
and its bile salt hydrolase (BSH) activity leading to the accumulation of intestinal tauro-β-muricholic acid (T-β-MCA). T-β-MCA is an farnesoid X receptor (FXR) nuclear receptor antagonist, whic...

Alternative Titles

Full title

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6595219

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6595219

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/ncomms3384

How to access this item